Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FM2PQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,594
Award facts
- Contract value 100% obligated
- $11,594.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,594.22 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose-2pen/mL pharmaceutical supplies. The award, issued on January 15, 2026, is structured as a firm fixed-price delivery order with an ultimate completion date of January 16, 2026. The contract carries no set-aside designation, indicating full and open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order represents a task order under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical.
This award falls under AmerisourceBergen's comprehensive pharmaceutical supply agreement with the Defense Logistics Agency, a single-award indefinite delivery contract valued at $999,999,999.00 and extending through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds an even larger IDC with DLA valued at approximately $1 billion through December 31, 2031. These contracts serve as critical vehicles for delivering a broad spectrum of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies to support military healthcare programs globally. The Cosentyx delivery order supports the Defense Health Agency and other federal healthcare systems' requirements for this immunosuppressive medication used in treating conditions such as psoriasis and rheumatoid arthritis.
Quick answers
Who was awarded contract SPE2DR26FM2PQ?
SPE2DR26FM2PQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FM2PQ worth?
The government has obligated $11,594 on SPE2DR26FM2PQ.
Is contract SPE2DR26FM2PQ an order under another contract?
Yes. SPE2DR26FM2PQ is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM2PQ competed?
The extent of competition for SPE2DR26FM2PQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award